Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Lydia D. Foster, Claudia S. Moy, Guohua Xi, Michael D. Hill, Lewis B. Morgenstern, Steven M. Greenberg, Michael L. James, Vineeta Singh, Wayne M. Clark,

The Lancet Neurology · 2019 · 249 citations · 27 references

DOIFull text

Open access

Concepts

References

27